Entries by Niki Markou

Announcement: Ionis Pharmaceuticals

Dear Lafora Disease Community, We have received a letter from Ionis Pharmaceuticals regarding the proposed clinical trials 2022.   This year has presented us with new challenges yet again. Continuing to Hope… We will never stop fighting for a cure. Our team is working tirelessly to uncover new ways to overcome our challenges. We will […]

RESEARCH PAPER: Lack of p62 Impairs Glycogen Aggregation and Exacerbates Pathology in a Mouse Model of Myoclonic Epilepsy of Lafora

Want to read some research on Lafora disease but a more simplified version? Well Dr Jordi Duran from the Institute for Research in Biomedicine (IRB Barcelona) in Barcelona, Spain has provided us with an easier version of his latest research paper for us to read. Research Paper: Lack of p62 Impairs Glycogen Aggregation and Exacerbates […]

We’re part of the @ChanZuckerbergInitiative’s #RareAsOne Network

A group of 50 patient-led organizations that are strengthening rare disease communities, improving diagnosis, accelerating research and driving progress in the fight against rare diseases. Learn more here. Patients are a powerful force in driving research for rare disease — we provide critical insights about our diseases and are fueling significant discoveries.7,000 rare diseases, one community […]